Home
Live Updates
Bivictrix says BVX001 increases survival rates by more than double : comparemela.com
Bivictrix says BVX001 increases survival rates by more than double
Bivictrix Therapeutics PLC on Thursday said its Bi-Cygni antibody-drug conjugate, BVX001, showed survival rates more than doubled in a pre-clinical model of acute myeloid leukaemia.
The...
Related Keywords
,
Alliance News ,
Bivictrix Therapeutics ,
Alliance News Ltd ,
Executive Officer Tiffany Thorn ,
Sabrina Penty ,
All Rights ,
Markets ,
comparemela.com © 2020. All Rights Reserved.